Skip to main content

Verónica Muñoz Canales, Ph.D.


Department of Natural Sciences
Chemistry


Education

Ph.D., Medicinal Chemistry, Universidad Complutense de Madrid
M.Sc., Organic Chemistry, Universidad Santiago de Compostela
B.A., Chemistry, Universidad de Castilla La Mancha

Practice Areas

  • Organic Chemistry
  • Chemical Biology

Publications and Media Placements

Souvik Adak; Verónica Muñoz-Canales; Surya Sekhar Manna; Krishnan Raghavachari; Silvia Ortega-Gutiérrez; Quentin Lefebvre; Christophe Salome; M. Kevin Brown. Ladderanes: Stepping up as nonclassical ortho-substituted benzene bioisosteres. JACS. 2026, 148, 23078.

Verónica Muñoz-Canales, Henar Vázquez-Villa, Bellinda Benhamú, Mar Martín-Fontecha, Silvia Ortega-Gutiérrez. Beyond classical cannabinoids: The development and therapeutic potential of next-generation ligands. Pharmacol. Res. 2025, 222, 108022.

"Cannabinoid-based chemical probes for the identification of relevant therapeutic targets in the immune system". XXI Congreso Nacional de Química Terapéutica (SEQT), Sevilla (Spain), 2025.

"Cannabinoid-based chemical probes for the identification of relevant therapeutic targets in the immune system". 2nd EFMC International Symposium on Chemical Biology (EFMC-ISCB), Basel, (Switzerland), 2025.

"Development of chemical probes for the identification of relevant target proteins in the immune system". 18th Annual CiM-IMPRS Graduate School Meeting team "Beyond the Cell: Unraveling life", Muenster (Germany), 2024.

"Development of chemical probes for the identification of relevant target proteins in the immune system". X Symposium of Medicinal Chemistry Young Researchers (SEQT), Madrid (Spain), 2024.

"Novel cannabinoid-based vaccines for allergic diseases". VIII SEQT Summer School "Medicinal chemistry and Chemical biology in Drug Discovery: The pharma perspective", Santiago de Compostela (Spain), 2023.

Novel cannabinoid-based vaccines for allergic diseases". IX Symposium of Medicinal Chemistry Young Researchers (SEQT), Santiago de Compostela (Spain), 2023.